English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells Journal article
Zhou, Guangyu, Fu, Shengyu, Zhang, Yunsen, Li, Shuang, Guo, Ziang, Ouyang, Defang, Ying, Tianlei, Lu, Yinying, Zhao, Qi. Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells[J]. Antibodies, 2024, 13(2), 45.
Authors:  Zhou, Guangyu;  Fu, Shengyu;  Zhang, Yunsen;  Li, Shuang;  Guo, Ziang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.0/4.7 | Submit date：2024/08/05
Car-t Cell  Her2  Monoclonal Antibody  Trastuzumab  
Clinical research advances in chimeric antigen receptor T - cell therapy for primary liver cancer 嵌合抗原受体 T 细胞治疗原发性肝癌临床研究进展 Journal article
Li,Shuang, Liu,Zherui, Lu,Yinying. Clinical research advances in chimeric antigen receptor T - cell therapy for primary liver cancer 嵌合抗原受体 T 细胞治疗原发性肝癌临床研究进展[J]. Journal of Clinical Hepatology, 2023, 39(5), 1019-1029.
Authors:  Li,Shuang;  Liu,Zherui;  Lu,Yinying
Favorite | TC[Scopus]:0 | Submit date：2023/08/03
Carcinoma, Hepatocellular  Chimeric Antigen  Receptors  T-lymphocytes  Therapeutics  
Clinical research advances in chimeric antigen receptor T-cell therapy for primary liver cancer Journal article
Li, Shuang, Liu, Zherui, Zhao, Qi, Lu,Yinying. Clinical research advances in chimeric antigen receptor T-cell therapy for primary liver cancer[J]. Journal of Clinical Hepatology, 2023, 39(5), 1019-1029.
Authors:  Li, Shuang;  Liu, Zherui;  Zhao, Qi;  Lu,Yinying
Favorite | TC[Scopus]:0 | Submit date：2023/08/28